Back to results
US 2026/0306839 A1Published application
Combination therapy for treatment of depression
AssigneeFlow Neuroscience, Inc.
InventorsDaniel MÅNSSON, Erik REHN
Life of this patent
Estimating the term…
Abstract
Provided are methods for treating depression and depression-related conditions by combining administration of pharmacologic agents and neuromodulation induced by transcranial electrical stimulation.
Claims30
A method of treating depression in a patient in need thereof comprising administering to the patient:
- (a) a selective serotonin reuptake inhibitor (SSRI);
- and
- (b) current to a forehead of the patient in a plurality of treatment sessions, the current being delivered to the forehead for a predetermined duration in each treatment session of the plurality of treatment sessions, the plurality of treatment sessions being at least 29 treatment sessions,
- wherein a lower dosage of the SSRI is administered to the patient as compared to an individual receiving the SSRI alone.
1 more element
A method of treating depression in a patient in need thereof comprising administering to the patient:
- (a) a selective serotonin reuptake inhibitor (SSRI);
- and
- (b) current to a forehead of the patient in a plurality of treatment sessions, the current being delivered to the forehead of the patient for a predetermined duration in each treatment session of the plurality of treatment sessions, the plurality of treatment sessions administered at a frequency of at least 3 treatment sessions per week over a period of at least 5 weeks,
- wherein a lower dosage of the SSRI is administered to the patient as compared to an individual receiving the SSRI alone.
1 more element
Dependencies are inferred from the claim text.